http://ocg.cancer.gov
Director: Daniela S. Gerhard, Ph.D.

OCG supplies a suite of technology, informatics, clones, reagents, and data to enable the cancer research community to pursue studies of the molecular mechanisms of cancer initiation and progression. OCG has recently:

• Completed the mammalian gene collection with clones for 90%−97% of human and mouse genes with specific transcripts.
• Discovered new genetic variations linked to prostate cancer risk and increased risk for breast cancer.
• Released a characterization dataset for diffuse large B-cell lymphoma, adding to existing datasets on childhood cancers such as leukemias, neuroblastoma, and osteosarcoma.